Prime Capital Investment Advisors LLC lifted its holdings in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 56.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,781 shares of the financial services provider’s stock after buying an additional 8,570 shares during the period. Prime Capital Investment Advisors LLC’s holdings in Aflac were worth $1,962,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of AFL. Fortitude Family Office LLC bought a new position in Aflac in the 4th quarter valued at about $25,000. CoreFirst Bank & Trust bought a new position in shares of Aflac during the fourth quarter worth approximately $25,000. Studio Investment Management LLC bought a new position in shares of Aflac during the fourth quarter worth approximately $27,000. Bruce G. Allen Investments LLC bought a new position in shares of Aflac during the fourth quarter worth approximately $32,000. Finally, Impact Partnership Wealth LLC increased its holdings in shares of Aflac by 471.4% during the third quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 330 shares during the period. 67.44% of the stock is currently owned by institutional investors and hedge funds.
Aflac Trading Down 0.3 %
NYSE:AFL opened at $85.16 on Tuesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.06 and a quick ratio of 0.06. The firm has a 50-day moving average of $81.82 and a 200-day moving average of $81.29. The company has a market cap of $49.00 billion, a PE ratio of 10.99, a PEG ratio of 2.33 and a beta of 0.91. Aflac Incorporated has a one year low of $64.06 and a one year high of $86.26.
Analyst Ratings Changes
Several research analysts have recently commented on AFL shares. Morgan Stanley lowered their target price on shares of Aflac from $85.00 to $80.00 and set an “equal weight” rating on the stock in a report on Friday, March 1st. The Goldman Sachs Group raised their target price on shares of Aflac from $61.00 to $75.00 and gave the company a “sell” rating in a research report on Tuesday, January 9th. Evercore ISI lowered shares of Aflac from an “in-line” rating to an “underperform” rating and raised their target price for the company from $76.00 to $78.00 in a research report on Thursday, January 4th. Wells Fargo & Company raised their target price on shares of Aflac from $82.00 to $83.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 6th. Finally, UBS Group raised their target price on shares of Aflac from $80.00 to $84.00 and gave the company a “neutral” rating in a research report on Wednesday, January 10th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $81.58.
View Our Latest Research Report on AFL
Insider Buying and Selling at Aflac
In other Aflac news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total value of $423,100.00. Following the transaction, the director now directly owns 17,920 shares in the company, valued at $1,516,390.40. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Aflac news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total value of $423,100.00. Following the transaction, the director now directly owns 17,920 shares in the company, valued at $1,516,390.40. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Albert Riggieri sold 8,000 shares of the company’s stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total transaction of $666,720.00. Following the sale, the senior vice president now owns 32,825 shares in the company, valued at $2,735,635.50. The disclosure for this sale can be found here. Insiders have sold a total of 46,493 shares of company stock worth $3,765,706 over the last three months. 0.80% of the stock is currently owned by insiders.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories
- Five stocks we like better than Aflac
- How to Invest in the FAANG Stocks
- Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
- What is MarketRankā¢? How to Use it
- The 5 Hottest CEO Stock Purchases So Far This Year
- There Are Different Types of Stock To Invest In
- Institutions Think This Consumer Stock Could Break Higher
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.